Cambridge Cognition Holdings Forum

"The specialist developer and distributor of computerised neuropsychological tests has announced its second distribution agreement for third party products this month. The deal announced last week confers to the Company the sole rights to market the MANUS Parkinson's Pen, a sensor pen for diagnosis and monitoring of neuromotor impairments, in academic research, pharmaceutical clinical trials and occupational health markets. The device is a CE marked Class I medical device." Hybridan note out this morning on research tree

finnCap note out this morning on research tree "Cambridge Cognition announced that it has signed an agreement with MANUS Neurodynamica, a UK-based healthcare technology company, to sell the MANUS Parkinson’s Pen for the diagnosis and monitoring of neuromotor impairments such as Parkinson’s in academic research, pharmaceutical clinical trials and occupational health markets."

Welcome to the new Cambridge Cognition Holdings stream forum! Messages posted in the Cambridge Cognition Holdings stream will be logged here for posterity.

finnCap's note out this morning: "Cambridge Cognition announced that it has signed an agreement with AnthroTronix in the US to sell DANA to European military organisations and occupational health providers in addition to its core global academic research and pharmaceutical clinical trials markets. The distribution agreement is illustrative of how the company intends to exploit is existing strong sales channels into the pharma clinical trials markets, by pushing more innovative content through them. We make..." on Research Tree